BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2872563)

  • 1. Multiple mu opiate receptors.
    Pasternak GW; Wood PJ
    Life Sci; 1986 May; 38(21):1889-98. PubMed ID: 2872563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple morphine and enkephalin receptors: biochemical and pharmacological aspects.
    Pasternak GW
    Ann N Y Acad Sci; 1986; 467():130-9. PubMed ID: 3014970
    [No Abstract]   [Full Text] [Related]  

  • 3. A multiplicity of opiate receptors and enkephalin neuronal systems.
    Snyder SH
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):9-12. PubMed ID: 6282818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL; Pasternak GW
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic competition between opiates and enkephalins: does it indicate the existence of a common high affinity ("mu-1") binding site?
    Sarne Y; Kenner A
    Life Sci; 1987 Aug; 41(5):555-62. PubMed ID: 3037227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors.
    Smith JR; Simon EJ
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):281-4. PubMed ID: 6244551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ; Millan MJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    Clark JA; Houghten R; Pasternak GW
    Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selectivity of [D-Ala2-O-benzyl-Ser5]-enkephalin on mu and delta opiate receptor subtypes].
    Ji XQ; Zhang HL; Liu S; Zou G
    Zhongguo Yao Li Xue Bao; 1985 Mar; 6(1):3-5. PubMed ID: 2986407
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel phencyclidine analog interacts selectively with mu opioid receptors.
    Itzhak Y; Simon EJ
    J Pharmacol Exp Ther; 1984 Aug; 230(2):383-6. PubMed ID: 6086884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine enkephalin noncompetitively inhibits the binding of [3H]naloxone to the opiate mu-recognition site: evidence for delta----mu binding site interactions in vitro.
    Rothman RB; Danks JA; Jacobson AE; Burke TR; Rice KC
    Neuropeptides; 1985 Jul; 6(4):351-63. PubMed ID: 2995865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC; Kouakou Y; Puget A; Moisand C
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study.
    Bodnar RJ; Williams CL; Lee SJ; Pasternak GW
    Brain Res; 1988 Apr; 447(1):25-34. PubMed ID: 2838129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate and opioid peptide binding in rat goldfish: further evidence for opiate receptor heterogeneity.
    Nishimura S; Pasternak GW
    Brain Res; 1982 Sep; 248(1):192-5. PubMed ID: 6289993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of calcium-channel blockers (CCB) on mu and delta opioid receptors in rat brain membranes.
    Schwarz S; Katki AG
    Prog Clin Biol Res; 1990; 328():109-12. PubMed ID: 2154761
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of beta-funaltrexamine on radiolabeled opioid binding.
    Recht LD; Pasternak GW
    Eur J Pharmacol; 1987 Aug; 140(2):209-14. PubMed ID: 2822439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.